BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  AcelRx Pharma Reports Publication of Manuscript Analyzing Sufentanil Sublingual Tablets in Patients With Postoperative Pain

  Conclusions of the study highlighted that sufentanil sublingual tablet 30 mcg was effective and well-tolerated for the management of moderate-to-severe acute pain following a variety of surgical procedures, including knee replacement, open-abdominal surgery and bunionectomy.

  November 16, 2017

   · 

  6 min read
• Drug Development

  Medicenna Presents Updates on Phase IIb Clinical Trial of MDNA55 at the Annual Meeting of the Society of Neuro-Oncology

  MDNA55, is the Company’s lead immunotherapeutic agent targeting the interleukin-4 receptor which is known to be over-expressed in brain tumors and the tumor micro-environment but not in healthy brain tissue.

  November 16, 2017

   · 

  5 min read
• Biotech Beach

  MabVax Therapeutics Regains Compliance With Nasdaq’s Minimum Stockholders’ Equity Listing Requirements

  The Company regained compliance with the stockholders’ equity requirement as a result of the completion of successful financings totaling $4.75M during the third quarter of 2017.

  November 16, 2017

   · 

  3 min read
• 

  Business

  Philadelphia Biotech Startup Context Therapeutics Names a New CFO, Effective Immediately

  The company is strengthening its team as it transitions to a clinical development stage company.

  November 16, 2017

   · 

  4 min read
• Policy

  Alnylam Initiates Rolling Submission of NDA to U.S. FDA for Patisiran for the Treatment of Hereditary ATTR (hATTR) Amyloidosis

  The company plans to complete submission by year-end.

  November 16, 2017

   · 

  9 min read
• Business

  Edico Genome Partners With Children’s Hospital Los Angeles to Accelerate Diagnoses, Enhance Somatic and Germline Research Initiatives With DRAGEN Bio-IT Platform

  Today at the AMP 2017 Annual Meeting, Edico Genome announced an affiliation with Children’s Hospital Los Angeles.

  November 16, 2017

   · 

  3 min read
• Business

  Former Williams-Sonoma CMO and Chief Strategy and Business Development Officer Appointed to SleepScore Labs Board of Directors

  Connolly joins SleepScore Labs after nearly four decades of leadership in a global, public company and brings significant e-commerce and marketing acumen to SleepScore Labs’ team of science and sleep experts.

  November 16, 2017

   · 

  3 min read
• 

  Business

  Swedish Medtech BrainCool Opens Up U.S. HQ in Maryland

  The company also appointed Bryan Nicholson as its U.S. Vice President of Operations.

  November 16, 2017

   · 

  3 min read
• British Columbia Securities Commission Revokes Cease Trade Order on PharmaCyte Biotech Securities

  The company is providing a summary overview, corporate history and status report to address a regulatory compliance request from the British Columbia Securities Commission.

  November 16, 2017

   · 

  9 min read
• BioCapital

  Lupus Foundation of America Release: Major Lupus Stem Cell Study Receives Funding

  The Lupus Foundation of America announced today it will provide $3.8M in funding over the next five years to support the first-of-its-kind clinical trial in the United States to evaluate adult mesenchymal stem cellsas a treatment for lupus.

  November 16, 2017

   · 

  2 min read